System Biosciences (SBI) is a biotech company organized around delivery of products and services to support molecular and cell biology research. The firm was an early provider of exosome research reagents and CRISPR/Cas9 vectorsto enable investigator quickly take advantage of the latest, most powerful approaches. With a state-of-the-art facility in Palo Alto CA and an experienced staff (many being PhD-level scientists) areas of expertise cover exosome research, genome engineering, cell biology, next-generation sequencing (NGS), qPCR microarrays, flow cytometry, and more.
